Context Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASCB
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
|
+$13.9M |
| 2 |
CNTM
ConnectM Technology Solutions, Inc. Common Stock
CNTM
|
+$7.81M |
| 3 |
EFHTU
EF Hutton Acquisition Corporation I Unit
EFHTU
|
+$5.38M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$4.9M |
| 5 |
SPEC
Spectaire Holdings, Inc. Common Stock
SPEC
|
+$4.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASCBU
A SPAC II Acquisition Corp. Unit
ASCBU
|
+$14M |
| 2 |
MCACU
Monterey Capital Acquisition Corporation Unit
MCACU
|
+$7.89M |
| 3 |
ELIQ
Electriq Power Holdings, Inc.
ELIQ
|
+$4.82M |
| 4 |
GTAC
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
|
+$4.75M |
| 5 |
IVCAU
Investcorp AI Acquisition Corp. Unit
IVCAU
|
+$4.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.03% |
| 2 | Technology | 4.13% |
| 3 | Healthcare | 2.98% |
| 4 | Industrials | 2.34% |
| 5 | Communication Services | 0.62% |
Similar funds
Context Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Context Capital Management held 650 positions worth $1.49B, up 6.2% from $1.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Context Capital Management withdrew a net $667M in Q3 2022, closing 61 positions and reducing 31 holdings. Its most notable exit was A SPAC II Acquisition Corp. Unit, an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Context Capital Management opened a new position in A SPAC II Acquisition Corp. Ordinary Shares worth $13.9M.
- Context Capital Management's largest Q3 2022 buy was A SPAC II Acquisition Corp. Ordinary Shares: 1,400,000 shares worth $13.9M.
- Context Capital Management added most to Churchill Capital Corp VII Class A Common Stock in Q3 2022, an estimated $4.9M increase.
- Context Capital Management's biggest Q3 2022 reduction was Aspire Biopharma, cutting an estimated $2.52M.
- Context Capital Management fully exited A SPAC II Acquisition Corp. Unit in Q3 2022, selling an estimated $14M.
- Context Capital Management's ten largest holdings make up 16% of its $1.49B portfolio in Q3 2022.
- Context Capital Management opened 22 new positions and closed 61 in Q3 2022.
- Context Capital Management's portfolio value rose 6.2% quarter-over-quarter to $1.49B.
Based on Context Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.